Coronavirus

Private debt has had to prove itself through one crisis after another, says AllianzGI’s Deborah Zurkow.

The second part of our A-Z looks at financing, growth, healthtech, infectious diseases, joint ownership and KOLs.

The pandemic has shone a spotlight on the importance of the healthcare sector. Some of the letter choices were more obvious than others: no surprise for guessing that C stands for covid.

In the first part of our A-Z, we examine ancillary healthcare, biotech, covid-19, digitisation and eldercare.

In the final part of our A-Z we look at visualisation, wellbeing, X-rays and diagnostics, youth services and Zoom healthcare.

The fourth part of our A-Z looks at quality of care, R&D, scalability, tie-ups and universal healthcare.

The third part of our A-Z looks at logistics, mental health, nursing homes, outcomes and pharmaceuticals.

Distressed investing has had a relatively quiet time of it, but that’s about to change. FocusPoint’s co-founder and CEO examines the pressures that are mounting up to create an explosion of opportunity

Volatile times call for new and perhaps unusual approaches. John Bakie takes a look at three investment firms with specific angles to weather changing environments

UK economic data has produced something of a shock, highlighting the need for private debt managers to consider the consequences of changed circumstances.